Editorial Approach & Evidence Governance
The values and goals that guide how CS Cancer Solutions presents oncology information
This page describes the principles and goals that guide content integrity, neutrality, and scientific accountability across the CS Cancer Solutions platform.
Last Updated: December 2025
This page describes the editorial principles and standards that guide content published on the CS Cancer Solutions platform.
CS Cancer Solutions aims to provide neutral, evidence-based oncology information and to limit political, religious, ideological, or commercial influence on content. Our goal is to support understanding and education—not to direct clinical decisions or advocate for specific courses of care.
These principles guide our work across pages, tools, and platform features.
Editorial independence is a core value and goal for all content on CS Cancer Solutions.
CS Cancer Solutions aims to avoid funding, partnerships, or incentives that would compromise editorial neutrality.
All oncology content is guided by the following principles, which describe our goals and approach:
1. Evidence-Based Sourcing
Content is drawn primarily from:
- Peer-reviewed scientific literature
- Regulatory and governmental sources (e.g., FDA, NCI)
- Public clinical trial registries (e.g., ClinicalTrials.gov)
- Established genomic and oncology databases
- Academic and institutional publications
Primary sources are cited whenever possible.
2. Transparency & Traceability
- Sources are clearly cited and accessible
- Evidence limitations are explicitly acknowledged
- Uncertainty and data gaps are disclosed
- Updates are timestamped when content is revised
3. Non-Prescriptive Scope
CS Cancer Solutions:
- Does not provide medical advice
- Does not recommend treatments
- Does not predict outcomes
- Does not replace clinical judgment
All content is educational and informational only.
4. Neutral Communication
Language across the platform is intentionally:
- Scientifically grounded
- Non-directive
- Non-emotive
- Free from moral, political, or religious framing
This approach is intended to support safe use by diverse institutions, clinicians, patients, and researchers.
We aim to review content when new evidence emerges
Content that has not been revisited recently is a candidate for reassessment
Major updates occur in response to:
- New regulatory approvals
- Significant clinical trial results
- Substantive changes in evidence interpretation
CS Cancer Solutions is designed to support informed conversations, not to influence or replace care decisions.
Clinical decisions should always be made by licensed healthcare professionals in consultation with patients and families.
CS Cancer Solutions is committed to maintaining:
These principles guide the development of the platform.
